EG19003A - Acyl derivatives of hydroxypyrimidines - Google Patents

Acyl derivatives of hydroxypyrimidines

Info

Publication number
EG19003A
EG19003A EG61388A EG61388A EG19003A EG 19003 A EG19003 A EG 19003A EG 61388 A EG61388 A EG 61388A EG 61388 A EG61388 A EG 61388A EG 19003 A EG19003 A EG 19003A
Authority
EG
Egypt
Prior art keywords
acyl derivatives
hydroxypyrimidines
substituted
compounds
useful
Prior art date
Application number
EG61388A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of EG19003A publication Critical patent/EG19003A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Liquid Carbonaceous Fuels (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Liquid Crystal Substances (AREA)
EG61388A 1987-12-02 1988-12-01 Acyl derivatives of hydroxypyrimidines EG19003A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/003171 WO1989005295A1 (en) 1987-12-02 1987-12-02 Acyl derivatives of hydroxypyrimidines

Publications (1)

Publication Number Publication Date
EG19003A true EG19003A (en) 1994-06-30

Family

ID=22202696

Family Applications (1)

Application Number Title Priority Date Filing Date
EG61388A EG19003A (en) 1987-12-02 1988-12-01 Acyl derivatives of hydroxypyrimidines

Country Status (26)

Country Link
EP (1) EP0319170B1 (de)
JP (1) JPH0725740B2 (de)
KR (1) KR910000415B1 (de)
CN (1) CN1033379A (de)
AT (1) ATE86983T1 (de)
AU (1) AU609547B2 (de)
CA (1) CA1336516C (de)
DD (1) DD277275A5 (de)
DE (1) DE3879410T2 (de)
DK (1) DK671188A (de)
EG (1) EG19003A (de)
ES (1) ES2053769T3 (de)
FI (1) FI893648A7 (de)
HU (1) HU206203B (de)
IE (1) IE63456B1 (de)
IL (1) IL88512A0 (de)
MX (1) MX14001A (de)
MY (1) MY103499A (de)
NO (1) NO893105L (de)
NZ (1) NZ227163A (de)
PL (1) PL158165B1 (de)
PT (1) PT89124B (de)
RU (1) RU2036909C1 (de)
WO (1) WO1989005295A1 (de)
YU (1) YU47013B (de)
ZA (1) ZA888969B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0449883B1 (de) * 1988-12-21 1996-01-31 Massachusetts Institute Of Technology Verfahren für laserinduzierte fluoreszenz von gewebe
US5270319A (en) * 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5220025A (en) * 1992-02-24 1993-06-15 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5196431A (en) * 1992-02-24 1993-03-23 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
TW440563B (en) * 1996-05-23 2001-06-16 Hoffmann La Roche Aryl pyrimidine derivatives and a pharmaceutical composition thereof
AU2003232650A1 (en) * 2003-05-06 2004-11-26 Il Yang Pharm Co., Ltd. N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
KR20170057191A (ko) * 2017-05-04 2017-05-24 김점식 유압을 이용한 전기 자동차 구동장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4711888A (en) * 1985-07-24 1987-12-08 Pfizer Inc. Hydroxy and alkoxy pyrimidines

Also Published As

Publication number Publication date
FI893648A0 (fi) 1989-08-01
WO1989005295A1 (en) 1989-06-15
EP0319170A2 (de) 1989-06-07
AU609547B2 (en) 1991-05-02
YU217988A (en) 1990-10-31
AU2647088A (en) 1989-06-08
IE63456B1 (en) 1995-04-19
YU47013B (sh) 1994-11-15
HU206203B (en) 1992-09-28
JPH01250364A (ja) 1989-10-05
DK671188D0 (da) 1988-12-01
NO893105L (no) 1989-09-27
NO893105D0 (no) 1989-08-01
MX14001A (es) 1993-06-01
PL158165B1 (pl) 1992-08-31
EP0319170B1 (de) 1993-03-17
RU2036909C1 (ru) 1995-06-09
CA1336516C (en) 1995-08-01
PL276122A1 (en) 1989-06-12
IL88512A0 (en) 1989-06-30
IE883598L (en) 1989-06-02
ZA888969B (en) 1990-07-25
DE3879410D1 (de) 1993-04-22
EP0319170A3 (en) 1990-08-01
MY103499A (en) 1993-06-30
KR890009890A (ko) 1989-08-04
HU894552D0 (en) 1990-11-28
FI893648A7 (fi) 1989-08-01
DE3879410T2 (de) 1993-06-24
PT89124A (pt) 1988-12-01
NZ227163A (en) 1990-11-27
DK671188A (da) 1989-07-28
KR910000415B1 (ko) 1991-01-25
ATE86983T1 (de) 1993-04-15
JPH0725740B2 (ja) 1995-03-22
DD277275A5 (de) 1990-03-28
PT89124B (pt) 1993-04-30
HUT55003A (en) 1991-04-29
CN1033379A (zh) 1989-06-14
ES2053769T3 (es) 1994-08-01

Similar Documents

Publication Publication Date Title
ES2000734A6 (es) Un procedimiento para la preparacion de pirimidinas
DE69730156D1 (de) 5-Pyrimidinyl-4-yl-imidazole derivatives useful for the treatment of CSBP/RK/p38 mediated diseases
AU2911489A (en) Quinoline derivatives as antagonists of leukotriene d4
FI913477L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten imidatsoli-fenyyli-imidatso/1,2-a/pyridiini- ja imidatsoli-fenyyli-imidatso/1,2-a/pyrimidiinijohdannaisten valmistamiseksi
NO931635L (no) Fremgangsmaate for fremstilling av kinazolin-derivater
FI954718L (fi) Heterosykliset johdannaiset iskeemian ja vastaavien sairauksien hoitamiseksi
MY119800A (en) Pyridine derivatives
EP0534363A3 (en) Novel 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
ZA200405602B (en) Nicotinamide derivatives useful as p38 inhibitors
NO950784L (no) Fettsyrederivater
NO871311D0 (no) Zwitterioniske bicykliske forbindelser og deres salter, solvater, hydrater og estere.
DE3888466D1 (de) 6-Arylaminomethylchinolin-Derivate und ihre Verwendung als Antitumorwirkstoff.
MY133125A (en) Novel dihydroxyhexanoic acid derivatives
PL276122A1 (en) Method of obtaining acyl derivatives of hydroxypyrimidines
DK23289D0 (da) Disubstituerede pyridinderivater, fremgangsmaade og mellemprodukter til deres fremstilling samt deres anvendelse
FI931204A0 (fi) Nya, saosom lipooxigenasinhibitorer verkande aminobensosultamderivat
DE58906618D1 (de) Strobilurinderivate, ihre Herstellung und Verwendung.
IT1142938B (it) Procedimento per la produzione di imidazo (4,5-b)-piridine e imidazo (4,5-b)-pirimidine
AU562435B2 (en) Substituted cyclopropenone for the treatment of alopecia areata and other dermatological diseases
FI972673A7 (fi) 4,4-(disubstituoitu)sykloheksan-1-oli-monomeereja ja vastaavia yhdiste itä
MX5313A (es) Derivados heterociclicos para el tratamiento de trastornos cardiovasculares y procedimiento para obtenerlos.
ATE30032T1 (de) N-acylderivate von dipeptiden, ihre herstellung und verwendung bei der therapie von krankheiten und mittel dafuer.
SE8300624D0 (sv) Foreningen 4-amino-6-(cyklohexylamino)-5-(formylamino)-2-(metyltio)-pyrimidin som mellanprodukt vid framstellning av 9-cyklohexyl-2-alkoxi-9h-adeninderivat
RU92016440A (ru) Производные гидрокси- и алкоксипиридинов
IT8363291V0 (it) Cornice amovibile perl'applicazione di pannelli ad ante di mobili o simili.